======= SPOCK3 ======= == Gene Information == * **Official Symbol**: SPOCK3 * **Official Name**: SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=50859|50859]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BQ16|Q9BQ16]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SPOCK3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SPOCK3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607989|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of a novel family of calcium-binding proteoglycan proteins that contain thyroglobulin type-1 and Kazal-like domains. The encoded protein and may play a role in adult T-cell leukemia by inhibiting the activity of membrane-type matrix metalloproteinases. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Oct 2011]. * **UniProt Summary**: N/A |SPARC Ca bdg| |Kazal 2| |Thyroglobulin 1| |Kazal 1| |peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan| |metalloendopeptidase inhibitor activity| |glycosaminoglycan binding| |extracellular matrix binding| |chondroitin sulfate metabolic process| |chondroitin sulfate proteoglycan metabolic process| |peptide cross-linking| |collagen binding| |proteoglycan metabolic process| |mucopolysaccharide metabolic process| |glycosaminoglycan metabolic process| |aminoglycan metabolic process| |peptidyl-serine modification| |negative regulation of endopeptidase activity| |negative regulation of peptidase activity| |negative regulation of cell motility| |negative regulation of cellular component movement| |negative regulation of locomotion| |negative regulation of proteolysis| |sulfur compound metabolic process| |glycoprotein metabolic process| |regulation of endopeptidase activity| |regulation of peptidase activity| |negative regulation of hydrolase activity| |calcium ion binding| |regulation of proteolysis| |negative regulation of catalytic activity| |peptidyl-amino acid modification| |regulation of cell motility| |regulation of locomotion| |regulation of cellular component movement| |oxoacid metabolic process| |organic acid metabolic process| |carbohydrate derivative metabolic process| |negative regulation of cellular protein metabolic process| |negative regulation of protein metabolic process| |negative regulation of molecular function| |regulation of hydrolase activity| |extracellular space| |small molecule metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp103|Taxol 0.004μM R03 exp103]]|-2.06| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|1.74| |[[:results:exp5|Alpha-Amanitin 0.5μM R00 exp5]]|1.84| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18695 * **Expression level (log2 read counts)**: -2.69 {{:chemogenomics:nalm6 dist.png?nolink |}}